290
Participants
Start Date
November 11, 2024
Primary Completion Date
November 30, 2032
Study Completion Date
November 30, 2032
Tebentafusp
Tebentafusp will be administered weekly i.v.
RECRUITING
Cliniques Universitaires Saint-Luc, Brussels
RECRUITING
Leiden University Medical Centre, Leiden
RECRUITING
Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin
RECRUITING
Universitaets Krankenhaus Eppendorf - Universitaetsklinikum Hamburg-Eppendorf KE - University Cancer Center, Hamburg
RECRUITING
Hospital Clinico Universitario De Valladolid, Valladolid
RECRUITING
Institut Curie - Hôpital de Paris, Paris
RECRUITING
Universitaetsklinikum Heidelberg - Frauenklinik / Hautklinik, Heidelberg
RECRUITING
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
RECRUITING
Institut Catala d'Oncologia - ICO L'Hospitalet - Hospital Duran i Reynals (Institut Catala D'Oncologia), L'Hospitalet de Llobregat
Collaborators (2)
Northwell Health
OTHER
Immunocore Ltd
INDUSTRY
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK